Lutz, Karen
Amylin Pharmaceuticals, San Diego, California.
3 papers on CoChat
Most cited papers
- Verified
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes
Edelman, S., Garg, S., Frias, J., Maggs, D., Wang, Y., Zhang, B., Strobel, S., Lutz, K., & Kolterman, O. (2006) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 166
- Verified
Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin
Riddle, M., Frias, J., Zhang, B., Maier, H., Brown, C., Lutz, K., & Kolterman, O. (2007) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 116
- Verified
Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes
Riddle, M., Pencek, R., Charenkavanich, S., Lutz, K., Wilhelm, K., & Porter, L. (2009) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 66
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free